297 related articles for article (PubMed ID: 29625602)
1. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
2. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
[TBL] [Abstract][Full Text] [Related]
3. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.
José Bento M; Gonçalves G; Aguiar A; Antunes L; Veloso V; Rodrigues V
J Med Screen; 2014 Jun; 21(2):104-9. PubMed ID: 24803482
[TBL] [Abstract][Full Text] [Related]
5. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
7. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
8. Five-Year Overall Survival of Interval Breast Cancers is Better than Non- Interval Cancers from Korean Breast Cancer Registry.
Lee JS; Kim HA; Cho SH; Lee HB; Park MH; Jeong J; Park HK; Oh M; Yi O
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1717-1726. PubMed ID: 31244292
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival.
Aarts MJ; Voogd AC; Duijm LE; Coebergh JW; Louwman WJ
Breast Cancer Res Treat; 2011 Jul; 128(2):517-25. PubMed ID: 21290176
[TBL] [Abstract][Full Text] [Related]
10. Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.
Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
Ann Surg Oncol; 2015 Nov; 22(12):3836-45. PubMed ID: 25743325
[TBL] [Abstract][Full Text] [Related]
11. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
12. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
13. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
14. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening mammography on breast cancer survival in comparison to other detection methods: a retrospective cohort study.
Kawai M; Kuriyama S; Suzuki A; Nishino Y; Ishida T; Ohnuki K; Amari M; Tsuji I; Ohuchi N
Cancer Sci; 2009 Aug; 100(8):1479-84. PubMed ID: 19493274
[TBL] [Abstract][Full Text] [Related]
16. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.
Domingo L; Blanch J; Servitja S; Corominas JM; Murta-Nascimento C; Rueda A; Redondo M; Castells X; Sala M
Eur J Cancer Prev; 2013 Jan; 22(1):21-8. PubMed ID: 22584215
[TBL] [Abstract][Full Text] [Related]
17. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
18. Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.
Sankatsing VDV; Fracheboud J; de Munck L; Broeders MJM; van Ravesteyn NT; Heijnsdijk EAM; Verbeek ALM; Otten JDM; Pijnappel RM; Siesling S; de Koning HJ;
BMC Cancer; 2018 Mar; 18(1):256. PubMed ID: 29506487
[TBL] [Abstract][Full Text] [Related]
19. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
20. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]